In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010154 | 4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010155 | ent-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010156 | ent-10-epi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010157 | ent-10-epi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010158 | ent-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010159 | 7-epi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010160 | 7,10-diepi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010161 | 7,10-diepi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010162 | 7-epi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010163 | ent-7-epi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010164 | ent-7,10-diepi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010165 | ent-7,10-diepi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010166 | ent-7-epi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010167 | 7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010168 | 10-epi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010169 | 10-epi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010170 | 7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010171 | ent-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010172 | ent-13-epi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010173 | ent-13-epi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010174 | ent-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010175 | 10-epi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010176 | 10,13-diepi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010177 | 10,13-diepi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010178 | 10-epi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010179 | ent-10-epi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010180 | ent-10,13-diepi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010181 | ent-10,13-diepi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010182 | ent-10-epi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010183 | 10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010184 | 13-epi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010185 | 13-epi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010186 | 10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010187 | ent-11-D4t-NeuroP | 3-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010188 | ent-4-epi-11-D4c-NeuroP | 3-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010189 | ent-4-epi-11-D4t-NeuroP | 3-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010190 | ent-11-D4c-NeuroP | 3-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010191 | 11-epi-11-D4c-NeuroP | 3-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010192 | 4,11-diepi-11-D4t-NeuroP | 3-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010193 | 4,11-diepi-11-D4c-NeuroP | 3-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010194 | 11-epi-11-D4t-NeuroP | 3-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010195 | ent-11-epi-11-D4t-NeuroP | 3-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010196 | ent-4,11-diepi-11-D4c-NeuroP | 3-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010197 | ent-4,11-diepi-11-D4t-NeuroP | 3-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010198 | ent-11-epi-11-D4c-NeuroP | 3-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010199 | 11-D4c-NeuroP | 3-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010200 | 4-epi-11-D4t-NeuroP | 3-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010201 | 4-epi-11-D4c-NeuroP | 3-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010202 | 11-D4t-NeuroP | 3-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
| LMFA04010203 | ent-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |